Hemlibra Lowered Number of Hemophilia A Bleeds Over Nearly 6 Years

Hemlibra Lowered Number of Hemophilia A Bleeds Over Nearly 6 Years

282243

Hemlibra Lowered Number of Hemophilia A Bleeds Over Nearly 6 Years

When given as a preventive treatment for nearly six years, Hemlibra (emicizumab) safely and effectively lowered the number of bleeding episodes in patients with severe hemophilia A, according to data from a Phase 1 clinical trial and its long-term extension study. Importantly, reductions in the number of bleeds that required treatment with blood-clotting agents were seen in all patients, regardless of the presence of inhibitors or prior prophylactic (preventive) treatment. Those findings were reported in…

You must be logged in to read/download the full post.